Considering that development of a hyperinflammatory phase is the main feature of the severe COVID-19 cases and given that immune cells can release gal3 during the inflammatory process (14, 15),we propose that it can be used as a biomarker of the inflammatory status in COVID-19 patients. The gene discussed is LGALS3; the disease is COVID-19.